NLRC5 overexpression is associated with CD8+ cytotoxic T cell activity14,15, promote the immunogenicity of tumors in human cancers16, studies showed that in EC, NLRC5 could inhibit tumor progression by activating immunosurveillance14,17. The gene discussed is NLRC5; the disease is neoplasm.